Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$358,845,965
-$94,810,587 QoQ
Shares Held
7,480,633
-36.3% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. RPRX ranks #2 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $358,845,965 | 7,480,633 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $453,656,552 | 11,740,594 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $422,147,532 | 11,965,633 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $216,180,000 | 6,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $194,562,500 | 6,250,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $432,861,868 | 16,968,321 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $336,628,198 | 11,899,194 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $288,275,020 | 10,931,931 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $328,510,194 | 10,816,931 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $306,094,791 | 10,896,931 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $267,057,600 | 9,840,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $265,901,000 | 8,650,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $261,032,558 | 7,244,867 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $276,640,000 | 7,000,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $328,069,700 | 8,165,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $702,396,542 | 16,707,815 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $967,872,176 | 24,842,715 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $989,982,192 | 24,842,715 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $892,579,034 | 24,697,815 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $931,367,196 | 22,721,815 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,076,879,916 | 24,687,756 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,937,649,714 | 38,714,280 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,935,864,933 | 46,015,330 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,234,044,271 | 46,015,330 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||